SAFER-DAPT
SAFINOUS-Assisted Framework for Evaluating Risk during Dual Antiplatelet Therapy.
Data Entry Form
Baseline & Laboratory
Age
Sex
Male
Female
Hemoglobin
g/dL
g/L
mmol
WBC Count
x10³/µL
cells/µL
CrCl
?
Creatinine
mg/dL
µmol/L
Clinical History
Prior Bleed
?
No Prior Bleeding
Yes, Prior Bleeding
Diabetes
No
Yes
Active Smoker
No
Yes
Dyslipidemia
No
Yes
Hypertension
No
Yes
Operative Details
EVH
?
No
Yes
Complex Grafts
?
No
Yes
Number of SVG
1
2
3
4
Graft Targets
No Diag
Diag
No LCx/OM
LCx/OM
No RCA
RCA
Clear Form
Run Risk Analysis
Clinical Report
Print
Download PDF
SAFINOUS Score
0.0
PRECISE-DAPT
0.0
CDRS+ Score
0.0
CRI Index
0.0%
Trajectory
Recommendation details.
Continuous Metrics Formulas
CDRS+ = max(0, 3·SAFINOUS - 2·PRECISE_DAPT + 100)
CRI% = [ (P(Isch) - P(Bleed) + 1.0) / 2.0 ] × 100%
Clinical Thresholds
High Ischemic:
CDRS+ ≥ 65 (Prolonged DAPT)
Balanced Risk:
40 ≤ CDRS+ < 65 (Short DAPT)
High Bleeding:
CDRS+ < 40 (Aspirin Mono)
Data Visualization
2D Map
3D Map
Feature Impact